The document discusses the lack of a widely available male contraceptive pill. While female contraception like the pill has been available since the 1950s, a male equivalent has proven more difficult to develop due to physiological differences between male and female reproduction. Several potential male contraceptive methods have been studied, including Gossypol and RISUG, but all have faced barriers like side effects or lack of funding. The responsibility of contraception is also seen as an impediment, as women may not trust their partners to take a male pill consistently. Overall, the document examines the challenges surrounding the development of an effective, reversible male contraceptive.
Optimizing The outcome of Threatened Abortion Dr Sharda Jain Lifecare Centre
- Around 70% of conceptions are lost prior to live birth, with 30% lost before implantation and 30% after implantation but before a missed period. Threatened abortion refers to vaginal bleeding or pain, or both, in early pregnancy when the cervical os remains closed.
- Studies have shown that counseling reduces adverse psychological effects from miscarriage. Treatment with dydrogesterone has been shown to reduce pregnancy loss in threatened abortion during the first trimester compared to placebo or no treatment. However, treatment with vaginal progesterone compared to placebo appears to have little effect on reducing miscarriage rates.
- Meta-analyses of multiple randomized controlled trials found that treatment with dydrogesterone for threatened miscarriage significantly reduced miscarriage
This document discusses the use of letrozole in infertility treatment. It begins by reviewing infertility and its typical treatments, such as intrauterine insemination and in vitro fertilization. It then discusses letrozole and aromatase inhibitors, noting that letrozole inhibits the aromatase enzyme to decrease estrogen levels. Several studies are summarized that compare the effects of letrozole to clomiphene in ovulation induction and assisted reproduction treatments. While letrozole appears to be relatively safe, the document concludes by questioning whether its theoretical advantages over clomiphene have been proven in practice.
Top Five Problems You Have with Ovulation Induction and How to Solve ThemSandro Esteves
The document discusses the top five problems with ovulation induction and how to solve them. It addresses whether protocols need to be individualized, how long clomiphene citrate should be used, the advantages of recombinant versus urinary gonadotropins, the advantages of recombinant versus urinary hCG, and whether LH supplementation is needed. It provides evidence-based recommendations including that protocols should be tailored based on biomarkers and individual factors, clomiphene citrate is usually first-line for up to 3 cycles, and recombinant gonadotropins yield higher pregnancy rates than clomiphene without increased risks.
1. The document discusses fertility options for women over age 40, what is realistic and not realistic. It provides data from studies on cumulative pregnancy rates, live birth rates, and ovarian response by age.
2. Case studies are presented of women over 40 seeking fertility treatment. For each case, the document recommends counseling and treatment strategies based on the woman's age, ovarian reserve tests, and previous response to treatment. These include tailored stimulation protocols, considering egg donation, or managing expectations.
3. Future potential strategies are discussed, such as accumulating vitrified eggs over time, using androgens or growth hormone to improve response, new stimulation protocols, and alternative sources of eggs if a woman's own eggs are not viable options
1. Prognostic models can help predict the chances of conceiving naturally, conceiving with interventions like IUI or IVF, and the chances of live birth from IVF.
2. Key factors in these models include female age, duration of infertility, cause of infertility, ovarian reserve tests, and data from previous treatment cycles.
3. Existing prediction models have been shown to have good discrimination and calibration for outcomes like IUI or IVF success, though individual patient preferences must also be considered in treatment decisions.
Recurrent pregnancy losses managing the unexplainedravikantraj55
This document discusses recurrent pregnancy losses and managing unexplained causes. It begins with an introduction to Dr. Manju Gita Mishra who has extensive experience in obstetrics and gynecology. The document then covers definitions of recurrent pregnancy loss, common causes, diagnostic evaluation, and treatment options including progesterone supplementation which some studies have found reduces subsequent miscarriage rates in women with unexplained recurrent miscarriages. It discusses challenges in identifying the cause in about 50% of recurrent pregnancy loss cases and stratifying women into those whose losses are likely due to chance versus an underlying abnormality.
Optimizing The outcome of Threatened Abortion Dr Sharda Jain Lifecare Centre
- Around 70% of conceptions are lost prior to live birth, with 30% lost before implantation and 30% after implantation but before a missed period. Threatened abortion refers to vaginal bleeding or pain, or both, in early pregnancy when the cervical os remains closed.
- Studies have shown that counseling reduces adverse psychological effects from miscarriage. Treatment with dydrogesterone has been shown to reduce pregnancy loss in threatened abortion during the first trimester compared to placebo or no treatment. However, treatment with vaginal progesterone compared to placebo appears to have little effect on reducing miscarriage rates.
- Meta-analyses of multiple randomized controlled trials found that treatment with dydrogesterone for threatened miscarriage significantly reduced miscarriage
This document discusses the use of letrozole in infertility treatment. It begins by reviewing infertility and its typical treatments, such as intrauterine insemination and in vitro fertilization. It then discusses letrozole and aromatase inhibitors, noting that letrozole inhibits the aromatase enzyme to decrease estrogen levels. Several studies are summarized that compare the effects of letrozole to clomiphene in ovulation induction and assisted reproduction treatments. While letrozole appears to be relatively safe, the document concludes by questioning whether its theoretical advantages over clomiphene have been proven in practice.
Top Five Problems You Have with Ovulation Induction and How to Solve ThemSandro Esteves
The document discusses the top five problems with ovulation induction and how to solve them. It addresses whether protocols need to be individualized, how long clomiphene citrate should be used, the advantages of recombinant versus urinary gonadotropins, the advantages of recombinant versus urinary hCG, and whether LH supplementation is needed. It provides evidence-based recommendations including that protocols should be tailored based on biomarkers and individual factors, clomiphene citrate is usually first-line for up to 3 cycles, and recombinant gonadotropins yield higher pregnancy rates than clomiphene without increased risks.
1. The document discusses fertility options for women over age 40, what is realistic and not realistic. It provides data from studies on cumulative pregnancy rates, live birth rates, and ovarian response by age.
2. Case studies are presented of women over 40 seeking fertility treatment. For each case, the document recommends counseling and treatment strategies based on the woman's age, ovarian reserve tests, and previous response to treatment. These include tailored stimulation protocols, considering egg donation, or managing expectations.
3. Future potential strategies are discussed, such as accumulating vitrified eggs over time, using androgens or growth hormone to improve response, new stimulation protocols, and alternative sources of eggs if a woman's own eggs are not viable options
1. Prognostic models can help predict the chances of conceiving naturally, conceiving with interventions like IUI or IVF, and the chances of live birth from IVF.
2. Key factors in these models include female age, duration of infertility, cause of infertility, ovarian reserve tests, and data from previous treatment cycles.
3. Existing prediction models have been shown to have good discrimination and calibration for outcomes like IUI or IVF success, though individual patient preferences must also be considered in treatment decisions.
Recurrent pregnancy losses managing the unexplainedravikantraj55
This document discusses recurrent pregnancy losses and managing unexplained causes. It begins with an introduction to Dr. Manju Gita Mishra who has extensive experience in obstetrics and gynecology. The document then covers definitions of recurrent pregnancy loss, common causes, diagnostic evaluation, and treatment options including progesterone supplementation which some studies have found reduces subsequent miscarriage rates in women with unexplained recurrent miscarriages. It discusses challenges in identifying the cause in about 50% of recurrent pregnancy loss cases and stratifying women into those whose losses are likely due to chance versus an underlying abnormality.
This document summarizes a presentation on the management of male infertility. It discusses diagnosis of male infertility including semen analysis and tests of sperm DNA integrity. It reviews medical treatments including antioxidants and treatments for specific conditions like varicocele and hypogonadism. Surgical treatments for varicocele are discussed. Assisted reproduction techniques are summarized including outcomes of ICSI for treated vs untreated varicocele and sperm retrieval techniques for obstructive and non-obstructive azoospermia. Key findings are that varicocele repair and antioxidant treatment can improve fertility outcomes, while sperm retrieved from the testes have lower DNA damage than ejaculated sperm.
1. The document discusses new concepts in infertility including updated WHO reference values for semen analysis, the use of ICSI for male factor infertility, and success rates varying based on the cause of infertility.
2. ICSI, where surgically retrieved sperm are injected into eggs, has become an established procedure for couples with male subfertility to have a biological child, with reassuring post-natal outcomes reported so far.
3. The success of IVF depends on the type of infertility, with male factor infertility seeing live birth rates around 40% and female factor infertility around 25%, higher than other causes of infertility.
This document discusses common pitfalls in infertility management and provides recommendations to avoid them. It notes that too many unnecessary investigations should be avoided, and that semen analysis guidelines have been updated. It recommends not performing procedures like tubal insufflation, D&C, or ovarian drilling without evidence of benefit. Overstimulation during ovarian induction and inappropriate drug responses are highlighted. The use of laparoscopic power morcellation is warned against due to cancer risk. While stem cells may help regenerate follicles in animal models of premature ovarian failure (POF), differentiation into human oocytes has not been achieved.
1. The document discusses fertility options for women over age 40, outlining what is realistic and not realistic based on medical literature.
2. It reviews factors that affect fertility for older women like ovarian reserve tests, response to ovarian stimulation, embryo quality, and success rates for IVF and cumulative live births from multiple cycles.
3. Options discussed include tailored stimulation protocols, embryo testing, oocyte accumulation, ovarian rejuvenation therapies, and even oocyte donation when a woman's own eggs may not lead to success.
This document provides an update on poor ovarian response and approaches to improving outcomes for women with poor ovarian reserve undergoing IVF treatment. The key points summarized are:
1) The PRIMA study found no difference in pregnancy outcomes between a mild ovarian stimulation protocol using 150 IU of FSH daily versus a conventional stimulation protocol using 450 IU of HMG daily for women with poor ovarian reserve, despite the mild protocol requiring fewer days of stimulation and lower gonadotropin doses.
2) While increasing gonadotropin doses does not improve pregnancy rates, supplementation with LH during stimulation may provide benefits for women with poor ovarian reserve based on prior studies.
3) A new approach called "dual stimulation"
L.A., a 29-year-old female, presented with a 7-year history of infertility despite frequent unprotected intercourse following her last successful delivery 7 years ago. Physical examination and tests revealed partial uterine synechiae (Asherman's syndrome). She underwent dilatation and curettage with insertion of an IUCD. Her partner's semen analysis was pending due to a delayed COVID-19 test result. Infertility workup and treatments were discussed.
This document discusses new concepts in oral contraceptive intake, specifically the 24/4 regimen. It begins by providing background on different generations of combined oral contraceptives. It then introduces the 24/4 regimen, which contains ethinylestradiol and drospirenone over 24 days followed by 4 hormone-free days. Studies show this regimen more effectively inhibits follicular development compared to the traditional 21/7 regimen. The 24/4 regimen provides 3 extra days of anti-mineralocorticoid and antiandrogenic effects, and may reduce hormone-withdrawal symptoms. A large observational study found the 24/4 regimen with drospirenone, specifically Yaz, had the lowest contraceptive failure rates including in
This document provides an overview of family planning. It begins with background on world population growth and demographics in Nigeria. Unchecked population growth can strain economic and environmental resources. Family planning aims to allow individuals to control fertility safely and effectively. The document then defines family planning and discusses various contraceptive methods like hormonal methods (pills, implants, injections), barrier methods (condoms, diaphragms), sterilization, and IUDs. It covers effectiveness, side effects, and considerations for different contraceptive options. The goal of family planning is to empower people to voluntarily achieve desired family size and spacing of births.
Menopausal hormone therapy (MHT) also called postmenopausal hormone therapy and hormone replacement therapy. Here is presentation on Menopausal hormone therapy by Dr. Laxmi Shrikhande
This document discusses the pros and cons of transferring embryos on day 5 (blastocyst stage) versus day 3. It raises questions about whether day 5 transfer should be routine practice and whether there are any adverse effects. Specifically, it notes that day 5 transfer is not suitable for all women, especially those with a limited number of embryos, and that an increased incidence of autism has been reported. It also discusses whether day 5 transfer is practical given the infrastructure needed, and whether it is really of any value if more than one embryo is being transferred. The conclusion is that day 5 transfer should only be offered for highly selected cases.
The document discusses the definition and management of poor ovarian response. Poor response is generally defined as women with low ovarian reserve or a poor response to ovarian stimulation. As women age, their ovarian reserve declines resulting in fewer remaining eggs. The infertility specialist aims to assess biological age by measuring remaining egg count. Treatment options discussed include clomiphene citrate, letrozole, metformin, gonadotropins, ovarian drilling, and various IVF protocols tailored for poor responders. No single treatment guarantees success, and expectations must be managed through counseling.
This document summarizes a panel discussion on the management of IVF pregnancies conducted by Delhi ISAR, Advance Fertility and Gynaecology Centre, and Madhukar Rainbow Group of Hospitals. The panelists provided expert opinions on topics like the choice of ART treatment, number of embryos to transfer, luteal phase support, anomaly screening, reduction of higher order multiples, antenatal follow-up, prevention of preterm labor, use of antenatal steroids, and delivery timing in twin pregnancies. The document emphasizes that IVF pregnancies require special care and management.
Individualisation of controlled ovarian stimulationAboubakr Elnashar
This document discusses individualizing controlled ovarian stimulation (COS) protocols based on a patient's ovarian reserve. It describes various ovarian reserve tests (ORTs) like AMH and AFC levels that can categorize patients' responses. Prediction models incorporating multiple factors are presented to anticipate poor or high responses and tailor gonadotropin starting doses. Treatment strategies for different POSEIDON patient groups aim to maximize oocyte yield, including increasing gonadotropin doses or adding medications like recombinant LH. Dual stimulation protocols within one cycle are also proposed.
The document provides information about the qualifications and achievements of Dr. Laxmi Shrikhande. It lists her positions including Chairperson Elect of ICOG, National Corresponding Editor of a journal, founder and president of various organizations. It also lists some of the awards she has received for her work in women's health and related fields. The document then provides her name and credentials as Medical Director of Shrikhande Fertility Clinic in Nagpur, Maharashtra.
How to prevent occurrence of severe ovarian hyperstimulation in IVF. Is there a way ? this talk will present a pilot randomised study that may shed the light on this
Most men consider care to prevent pregnancy feminine duty. And yet, to take active part in the defense of their partners from unintended pregnancy, men can and should. Here are some examples of all currently existing methods of male contraception. Let’s consider the most common and used methods of methods of birth control for men and check their efficacy profile.
This document summarizes a presentation on the management of male infertility. It discusses diagnosis of male infertility including semen analysis and tests of sperm DNA integrity. It reviews medical treatments including antioxidants and treatments for specific conditions like varicocele and hypogonadism. Surgical treatments for varicocele are discussed. Assisted reproduction techniques are summarized including outcomes of ICSI for treated vs untreated varicocele and sperm retrieval techniques for obstructive and non-obstructive azoospermia. Key findings are that varicocele repair and antioxidant treatment can improve fertility outcomes, while sperm retrieved from the testes have lower DNA damage than ejaculated sperm.
1. The document discusses new concepts in infertility including updated WHO reference values for semen analysis, the use of ICSI for male factor infertility, and success rates varying based on the cause of infertility.
2. ICSI, where surgically retrieved sperm are injected into eggs, has become an established procedure for couples with male subfertility to have a biological child, with reassuring post-natal outcomes reported so far.
3. The success of IVF depends on the type of infertility, with male factor infertility seeing live birth rates around 40% and female factor infertility around 25%, higher than other causes of infertility.
This document discusses common pitfalls in infertility management and provides recommendations to avoid them. It notes that too many unnecessary investigations should be avoided, and that semen analysis guidelines have been updated. It recommends not performing procedures like tubal insufflation, D&C, or ovarian drilling without evidence of benefit. Overstimulation during ovarian induction and inappropriate drug responses are highlighted. The use of laparoscopic power morcellation is warned against due to cancer risk. While stem cells may help regenerate follicles in animal models of premature ovarian failure (POF), differentiation into human oocytes has not been achieved.
1. The document discusses fertility options for women over age 40, outlining what is realistic and not realistic based on medical literature.
2. It reviews factors that affect fertility for older women like ovarian reserve tests, response to ovarian stimulation, embryo quality, and success rates for IVF and cumulative live births from multiple cycles.
3. Options discussed include tailored stimulation protocols, embryo testing, oocyte accumulation, ovarian rejuvenation therapies, and even oocyte donation when a woman's own eggs may not lead to success.
This document provides an update on poor ovarian response and approaches to improving outcomes for women with poor ovarian reserve undergoing IVF treatment. The key points summarized are:
1) The PRIMA study found no difference in pregnancy outcomes between a mild ovarian stimulation protocol using 150 IU of FSH daily versus a conventional stimulation protocol using 450 IU of HMG daily for women with poor ovarian reserve, despite the mild protocol requiring fewer days of stimulation and lower gonadotropin doses.
2) While increasing gonadotropin doses does not improve pregnancy rates, supplementation with LH during stimulation may provide benefits for women with poor ovarian reserve based on prior studies.
3) A new approach called "dual stimulation"
L.A., a 29-year-old female, presented with a 7-year history of infertility despite frequent unprotected intercourse following her last successful delivery 7 years ago. Physical examination and tests revealed partial uterine synechiae (Asherman's syndrome). She underwent dilatation and curettage with insertion of an IUCD. Her partner's semen analysis was pending due to a delayed COVID-19 test result. Infertility workup and treatments were discussed.
This document discusses new concepts in oral contraceptive intake, specifically the 24/4 regimen. It begins by providing background on different generations of combined oral contraceptives. It then introduces the 24/4 regimen, which contains ethinylestradiol and drospirenone over 24 days followed by 4 hormone-free days. Studies show this regimen more effectively inhibits follicular development compared to the traditional 21/7 regimen. The 24/4 regimen provides 3 extra days of anti-mineralocorticoid and antiandrogenic effects, and may reduce hormone-withdrawal symptoms. A large observational study found the 24/4 regimen with drospirenone, specifically Yaz, had the lowest contraceptive failure rates including in
This document provides an overview of family planning. It begins with background on world population growth and demographics in Nigeria. Unchecked population growth can strain economic and environmental resources. Family planning aims to allow individuals to control fertility safely and effectively. The document then defines family planning and discusses various contraceptive methods like hormonal methods (pills, implants, injections), barrier methods (condoms, diaphragms), sterilization, and IUDs. It covers effectiveness, side effects, and considerations for different contraceptive options. The goal of family planning is to empower people to voluntarily achieve desired family size and spacing of births.
Menopausal hormone therapy (MHT) also called postmenopausal hormone therapy and hormone replacement therapy. Here is presentation on Menopausal hormone therapy by Dr. Laxmi Shrikhande
This document discusses the pros and cons of transferring embryos on day 5 (blastocyst stage) versus day 3. It raises questions about whether day 5 transfer should be routine practice and whether there are any adverse effects. Specifically, it notes that day 5 transfer is not suitable for all women, especially those with a limited number of embryos, and that an increased incidence of autism has been reported. It also discusses whether day 5 transfer is practical given the infrastructure needed, and whether it is really of any value if more than one embryo is being transferred. The conclusion is that day 5 transfer should only be offered for highly selected cases.
The document discusses the definition and management of poor ovarian response. Poor response is generally defined as women with low ovarian reserve or a poor response to ovarian stimulation. As women age, their ovarian reserve declines resulting in fewer remaining eggs. The infertility specialist aims to assess biological age by measuring remaining egg count. Treatment options discussed include clomiphene citrate, letrozole, metformin, gonadotropins, ovarian drilling, and various IVF protocols tailored for poor responders. No single treatment guarantees success, and expectations must be managed through counseling.
This document summarizes a panel discussion on the management of IVF pregnancies conducted by Delhi ISAR, Advance Fertility and Gynaecology Centre, and Madhukar Rainbow Group of Hospitals. The panelists provided expert opinions on topics like the choice of ART treatment, number of embryos to transfer, luteal phase support, anomaly screening, reduction of higher order multiples, antenatal follow-up, prevention of preterm labor, use of antenatal steroids, and delivery timing in twin pregnancies. The document emphasizes that IVF pregnancies require special care and management.
Individualisation of controlled ovarian stimulationAboubakr Elnashar
This document discusses individualizing controlled ovarian stimulation (COS) protocols based on a patient's ovarian reserve. It describes various ovarian reserve tests (ORTs) like AMH and AFC levels that can categorize patients' responses. Prediction models incorporating multiple factors are presented to anticipate poor or high responses and tailor gonadotropin starting doses. Treatment strategies for different POSEIDON patient groups aim to maximize oocyte yield, including increasing gonadotropin doses or adding medications like recombinant LH. Dual stimulation protocols within one cycle are also proposed.
The document provides information about the qualifications and achievements of Dr. Laxmi Shrikhande. It lists her positions including Chairperson Elect of ICOG, National Corresponding Editor of a journal, founder and president of various organizations. It also lists some of the awards she has received for her work in women's health and related fields. The document then provides her name and credentials as Medical Director of Shrikhande Fertility Clinic in Nagpur, Maharashtra.
How to prevent occurrence of severe ovarian hyperstimulation in IVF. Is there a way ? this talk will present a pilot randomised study that may shed the light on this
Most men consider care to prevent pregnancy feminine duty. And yet, to take active part in the defense of their partners from unintended pregnancy, men can and should. Here are some examples of all currently existing methods of male contraception. Let’s consider the most common and used methods of methods of birth control for men and check their efficacy profile.
This document discusses 10 factors that can negatively impact sperm and male fertility:
1. Overheating of the testes, such as from hot tubs, fevers, or laptop use on the lap can temporarily decrease sperm production for months.
2. Tight underwear like briefs or tight bike shorts can constrict the testes and hamper sperm production.
3. Varicose veins in the scrotum may disrupt blood flow and overheat the testes.
4. Cell phone radiation exposure has been linked to lower sperm counts and quality in some studies.
5. Obesity is associated with lower testosterone and sperm counts in men.
6. Smoking, drinking alcohol
Gaxiola male birth control pill presentationcarriegaxiola
Research into a male birth control pill has been ongoing for 20-40 years across several countries. A potential pill contains the hormone progestogen to reduce sperm counts to zero, with effects reversing after stopping the pill. Some men may be interested in a male pill as an option for contraception, while others have concerns about side effects or a pill challenging traditional gender roles. A major challenge is pharmaceutical companies do not see sufficient demand to invest in developing a male pill.
This was a fictional health communications campaign plan to bring awareness of birth control options for women over the age of 40. Even at 40, many women are still at risk for unintended, naturally occurring pregnancies. However, what worked in our younger years may not necessarily work as we get older.
Reproductive health refers to total well-being in all aspects of reproduction including physical, emotional, behavioral, and social factors. A reproductively healthy society has physically and functionally normal reproductive organs as well as normal emotional and behavioral interactions among individuals regarding sex. Reproductive and child health programs aim to create awareness about reproduction and provide support for building healthy societies. Introducing sex education in schools can provide accurate information to youth and discourage myths, while educating all groups on issues like family planning and maternal/child care can address building socially healthy communities.
New product dedisions provide a dear path to the business. New product development
astep by step process. A Complete idea is required behind new product.
1 1deal Generation: The development of a product starts with the concept and idea.
The remaining process is depending on that idea.
2 Screening of Idea: This step is cruial to ensure that unsuitable ideas, for whatever
reason, are rejected as soon as possible. Ideas need to be considered objectively,
ideally by a group or committee.
3. Concept Development and Testing: After having an idea, next is the sreening
stage. The idea should now convert into concept. It has depth information which can
be visualizing by the consumer.
4. Anaysis of business: After finalization of concept, a business case needs to be kept
algTStogether to consider whether the new service /product will be gainful.
2665.Product Development If the nev product is approved, it will be approved to the
2marketing and technical development step.
6. Test Marketing: Market testing (test marketing or) is different to consumer testing.
in that it introduces the product that follows proposed plan of marketing.
od7. Commercialization: When the concept has been tested and developed, final
0decisions are required to move the product to its introduction into the market.
8. Launch: A detailed plan of launch is required for this step. This is the important
stage for success of a product
New Drug Development
So In present business atmosphere, it is more important to take smart decisions for
business. Innovative approaches and new products can put an organization on proper
pathway and to make a big success if appropriately analyzed and executed. Make it simpler
(Fig.2.1).0
Following parameters should keep in mind for a better decision:
Analyzing existing service and product portfolio frequently.
Knowing the position of functions of business, projects of departments and
initiatives.
Understanding the distribution of funds and assessing efficiency.
Having understanding of market for new opportunities and possible competition.
2.B PRODUCT BRANDING, PACKAGING AND LABELLING DECİSIONs
2.8.1 Branding
Branding has its existence from ancient era. According to Nilson (2000), the first example
of branding is found in the oil lamps' manufacture on the Greek islands thousands of years
back. Brand elements are name, sign, term, symbol, design or distinguishing characteristics.
Brand is not only a graphical design or a logo; it is the unique identity of the product.
By American Marketing Association, Brand can be defined as name, term, sign, symbol
or design, or a combination of them intended to identijy the goods and services of one seller or
group of sellers and to diferentiate them from those of other sellersa54
Branding is a process, where a company generates loyalty among consumers in the
market. Brands are designed with a motive to communicate customers the reason for the
existence of their product. Brand should have a strong connection with customers;
The document discusses different types of birth control, including natural, hormonal, barrier, implantable, and permanent methods. It provides details on popular options like the pill, patch, shot, ring, condoms, diaphragm, IUD, and implant. The importance of considering factors like effectiveness, side effects, and convenience when choosing a method is emphasized.
The Trak Male Fertility Testing System is the first FDA-cleared at-home male fertility test that allows men to conveniently measure their sperm count from home. The easy-to-use device pairs with a mobile app to provide personalized feedback and tips to help men improve their reproductive health. Clinical studies show the Trak system produces results that are as precise as laboratory tests. The launch of Trak will help tackle male infertility by empowering men to be proactive in evaluating and tracking their fertility health privately at home.
Technology using stem cells as a platform for developing reproductive organoi...ishikachoudhary6
Stem cells are being researched as a potential treatment for infertility. Stem cell-generated organoids may help diagnose and model reproductive diseases. Researchers have used stem cells from embryos, bone marrow, and umbilical cord to treat male and female infertility issues. Stem cell therapy aims to improve sperm and egg production to increase fertility levels. While clinical trials are promising, stem cell treatment for infertility is still experimental and not FDA approved. The potential benefits include less invasiveness and cost compared to IVF, though risks like infection need to be considered.
Sex in Three Cities Lecture 2014, Our Reproductive Future 2013UoN
This document discusses the future of human reproduction and fertility. It notes that while assisted reproductive technologies are increasingly used by older couples, contraceptive research and development has been neglected. Over 44 million abortions occur worldwide each year due to lack of effective contraception. The author argues we should invest more in contraceptive research given its potential impact. The document also examines how female fertility sharply declines after age 35, while male fertility is more stable with age. It concludes that while IVF cannot overcome the effects of age on eggs, freezing eggs may help preserve fertility.
Family planning refers to practices that help individuals or couples attain objectives related to controlling birth timing and spacing. These include avoiding unwanted births, regulating pregnancy intervals, and determining family size. Methods include natural family planning techniques, barrier methods like condoms and diaphragms, hormonal contraceptives, intrauterine devices, and permanent sterilization procedures. Pharmacists can play a key role in educating the public about family planning options and promoting healthy birth spacing.
Family planning refers to practices that help individuals or couples attain objectives related to controlling birth timing and spacing. These include avoiding unwanted births, bringing about wanted births, regulating pregnancy intervals, and determining family size. Methods include behavioral, natural, chemical, mechanical, hormonal, and terminal options. The document outlines various contraceptive methods and their use, benefits, and limitations. The role of pharmacists is to educate the public about family planning in their local language to promote its acceptance and use.
This presentation include a short description about the importance of family planning, various methods such as biological, mechanical, chemical and biological methods that are adopted in family planning and role of pharmacist in family planning etc.methods include mainly usage of pills, condoms, abstinance, withdrawal, IUDs, and terminational methods such as vasectomy and tubectomy
The document discusses various aspects of reproductive health according to the WHO definition and strategies to address reproductive health issues. It outlines problems like overpopulation and the need for family planning, maternal healthcare, sex education, and access to reproductive services. Natural family planning methods, barrier methods like condoms and diaphragms, and medical contraceptives including IUDs, oral pills, implants, and emergency contraception are explained. Surgical sterilization methods for permanent contraception are also mentioned.
This document summarizes different methods of contraception, including barrier methods (such as condoms), hormonal methods (oral contraceptives, patches, rings, implants, injections), natural family planning methods, and surgical methods (vasectomies, tubal ligations). It discusses factors to consider when choosing a method like effectiveness, advantages, disadvantages, side effects, and protection against STDs. Surgical methods and long-acting reversible contraceptives like implants are the most effective, while fertility awareness methods and withdrawal are the least effective. Education on contraception and addressing gender differences are important considerations.
Dr. Anne Peterson, MD, MPH explains how using family planning to safely time and space births improves maternal and child health and survival and reduces abortion rates. Dr. Peterson also explains how recent research has shown previous beliefs that some contraceptive methods were abortifacients to be inaccurate.
Similar to Why don't we have a male contraceptive pill yet (20)
PPT on Sustainable Land Management presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
Compositions of iron-meteorite parent bodies constrainthe structure of the pr...Sérgio Sacani
Magmatic iron-meteorite parent bodies are the earliest planetesimals in the Solar System,and they preserve information about conditions and planet-forming processes in thesolar nebula. In this study, we include comprehensive elemental compositions andfractional-crystallization modeling for iron meteorites from the cores of five differenti-ated asteroids from the inner Solar System. Together with previous results of metalliccores from the outer Solar System, we conclude that asteroidal cores from the outerSolar System have smaller sizes, elevated siderophile-element abundances, and simplercrystallization processes than those from the inner Solar System. These differences arerelated to the formation locations of the parent asteroids because the solar protoplane-tary disk varied in redox conditions, elemental distributions, and dynamics at differentheliocentric distances. Using highly siderophile-element data from iron meteorites, wereconstruct the distribution of calcium-aluminum-rich inclusions (CAIs) across theprotoplanetary disk within the first million years of Solar-System history. CAIs, the firstsolids to condense in the Solar System, formed close to the Sun. They were, however,concentrated within the outer disk and depleted within the inner disk. Future modelsof the structure and evolution of the protoplanetary disk should account for this dis-tribution pattern of CAIs.
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptxshubhijain836
Centrifugation is a powerful technique used in laboratories to separate components of a heterogeneous mixture based on their density. This process utilizes centrifugal force to rapidly spin samples, causing denser particles to migrate outward more quickly than lighter ones. As a result, distinct layers form within the sample tube, allowing for easy isolation and purification of target substances.
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...Scintica Instrumentation
Targeting Hsp90 and its pathogen Orthologs with Tethered Inhibitors as a Diagnostic and Therapeutic Strategy for cancer and infectious diseases with Dr. Timothy Haystead.
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...Sérgio Sacani
Context. The observation of several L-band emission sources in the S cluster has led to a rich discussion of their nature. However, a definitive answer to the classification of the dusty objects requires an explanation for the detection of compact Doppler-shifted Brγ emission. The ionized hydrogen in combination with the observation of mid-infrared L-band continuum emission suggests that most of these sources are embedded in a dusty envelope. These embedded sources are part of the S-cluster, and their relationship to the S-stars is still under debate. To date, the question of the origin of these two populations has been vague, although all explanations favor migration processes for the individual cluster members. Aims. This work revisits the S-cluster and its dusty members orbiting the supermassive black hole SgrA* on bound Keplerian orbits from a kinematic perspective. The aim is to explore the Keplerian parameters for patterns that might imply a nonrandom distribution of the sample. Additionally, various analytical aspects are considered to address the nature of the dusty sources. Methods. Based on the photometric analysis, we estimated the individual H−K and K−L colors for the source sample and compared the results to known cluster members. The classification revealed a noticeable contrast between the S-stars and the dusty sources. To fit the flux-density distribution, we utilized the radiative transfer code HYPERION and implemented a young stellar object Class I model. We obtained the position angle from the Keplerian fit results; additionally, we analyzed the distribution of the inclinations and the longitudes of the ascending node. Results. The colors of the dusty sources suggest a stellar nature consistent with the spectral energy distribution in the near and midinfrared domains. Furthermore, the evaporation timescales of dusty and gaseous clumps in the vicinity of SgrA* are much shorter ( 2yr) than the epochs covered by the observations (≈15yr). In addition to the strong evidence for the stellar classification of the D-sources, we also find a clear disk-like pattern following the arrangements of S-stars proposed in the literature. Furthermore, we find a global intrinsic inclination for all dusty sources of 60 ± 20◦, implying a common formation process. Conclusions. The pattern of the dusty sources manifested in the distribution of the position angles, inclinations, and longitudes of the ascending node strongly suggests two different scenarios: the main-sequence stars and the dusty stellar S-cluster sources share a common formation history or migrated with a similar formation channel in the vicinity of SgrA*. Alternatively, the gravitational influence of SgrA* in combination with a massive perturber, such as a putative intermediate mass black hole in the IRS 13 cluster, forces the dusty objects and S-stars to follow a particular orbital arrangement. Key words. stars: black holes– stars: formation– Galaxy: center– galaxies: star formation
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆Sérgio Sacani
Context. The early-type galaxy SDSS J133519.91+072807.4 (hereafter SDSS1335+0728), which had exhibited no prior optical variations during the preceding two decades, began showing significant nuclear variability in the Zwicky Transient Facility (ZTF) alert stream from December 2019 (as ZTF19acnskyy). This variability behaviour, coupled with the host-galaxy properties, suggests that SDSS1335+0728 hosts a ∼ 106M⊙ black hole (BH) that is currently in the process of ‘turning on’. Aims. We present a multi-wavelength photometric analysis and spectroscopic follow-up performed with the aim of better understanding the origin of the nuclear variations detected in SDSS1335+0728. Methods. We used archival photometry (from WISE, 2MASS, SDSS, GALEX, eROSITA) and spectroscopic data (from SDSS and LAMOST) to study the state of SDSS1335+0728 prior to December 2019, and new observations from Swift, SOAR/Goodman, VLT/X-shooter, and Keck/LRIS taken after its turn-on to characterise its current state. We analysed the variability of SDSS1335+0728 in the X-ray/UV/optical/mid-infrared range, modelled its spectral energy distribution prior to and after December 2019, and studied the evolution of its UV/optical spectra. Results. From our multi-wavelength photometric analysis, we find that: (a) since 2021, the UV flux (from Swift/UVOT observations) is four times brighter than the flux reported by GALEX in 2004; (b) since June 2022, the mid-infrared flux has risen more than two times, and the W1−W2 WISE colour has become redder; and (c) since February 2024, the source has begun showing X-ray emission. From our spectroscopic follow-up, we see that (i) the narrow emission line ratios are now consistent with a more energetic ionising continuum; (ii) broad emission lines are not detected; and (iii) the [OIII] line increased its flux ∼ 3.6 years after the first ZTF alert, which implies a relatively compact narrow-line-emitting region. Conclusions. We conclude that the variations observed in SDSS1335+0728 could be either explained by a ∼ 106M⊙ AGN that is just turning on or by an exotic tidal disruption event (TDE). If the former is true, SDSS1335+0728 is one of the strongest cases of an AGNobserved in the process of activating. If the latter were found to be the case, it would correspond to the longest and faintest TDE ever observed (or another class of still unknown nuclear transient). Future observations of SDSS1335+0728 are crucial to further understand its behaviour. Key words. galaxies: active– accretion, accretion discs– galaxies: individual: SDSS J133519.91+072807.4
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Signatures of wave erosion in Titan’s coastsSérgio Sacani
The shorelines of Titan’s hydrocarbon seas trace flooded erosional landforms such as river valleys; however, it isunclear whether coastal erosion has subsequently altered these shorelines. Spacecraft observations and theo-retical models suggest that wind may cause waves to form on Titan’s seas, potentially driving coastal erosion,but the observational evidence of waves is indirect, and the processes affecting shoreline evolution on Titanremain unknown. No widely accepted framework exists for using shoreline morphology to quantitatively dis-cern coastal erosion mechanisms, even on Earth, where the dominant mechanisms are known. We combinelandscape evolution models with measurements of shoreline shape on Earth to characterize how differentcoastal erosion mechanisms affect shoreline morphology. Applying this framework to Titan, we find that theshorelines of Titan’s seas are most consistent with flooded landscapes that subsequently have been eroded bywaves, rather than a uniform erosional process or no coastal erosion, particularly if wave growth saturates atfetch lengths of tens of kilometers.
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
PPT on Alternate Wetting and Drying presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
The cost of acquiring information by natural selection
Why don't we have a male contraceptive pill yet
1. Arianna Toledo
Markham College
Scientific Research
02 December 2021
Why Don't We Have a Male Contraceptive Pill Yet?
“It makes more sense to take the bullets out of the gun than wear a bulletproof vest”, says the American
comedian, Greg Travis (Majumdar, 2018).1 Although meant as a joke, the truth is that male contraception would
be an attractive option in the future to reduce the responsibility of contraception from women. Historically,
contraception for men has been less optimal: abstention, which is not a solution; withdrawal, an ineffective
method; condoms, which are not always effective; and a vasectomy, which is a permanent solution, and daunting
for many people (Bakare, 2019).2 Thus, the question arises: why don’t we have a male contraceptive pill yet?
Contraception has existed since around 1850 BC, yet the pill, a more modern invention, was just introduced in
the 1950s, facing large opposition, even in the 21st century, from governments and religions. However, it is visible
how the birth control pill has revolutionized countless lives of women. Today, we debate the male birth control
pill: its intricacies and difficulties. Unfortunately, research on hormonal and non-hormonal treatments has been
conducted for decades, yet the side effects, on-going drug trials, and the conception of shared contraceptive
responsibility, pose important barriers to male birth control.
CONTEXT
1 Majumdar, M., 2018. Safe, Effective Male Contraceptive Pill - The Long Wait. [online] Medindia. Available at:
<https://www.medindia.net/patients/patientinfo/safe-effective-male-contraceptive-pill-the-long-wait.htm> [Accessed 2
December 2021].
2 Bakare, T., 2019. ‘The pill’ for guys: Male birth control option passes safety tests: UT Southwestern - MedBlog.
[online] Utswmed.org. Available at: <https://utswmed.org/medblog/pill-guys-male-birth-control-option-passes-safety-tests/>
[Accessed 2 December 2021].
2. 2
Birth control is a method of preventing pregnancy, also known as contraception. There are various types
of contraception, such as, preventing sperm from reaching the eggs, stopping ovulation, thickening the cervical
mucus preventing sperm entering the uterus (Rinkunas, 2016),3 and sterilization, which impedes a woman getting
pregnant (Birth Control | Contraception | Contraceptives | MedlinePlus, 2021).4 Each of these methods suits
different people, situations, and preferences. However, the main drawback of these contraceptives is that they are
mainly for women, and the few that are intended for men are less effective.
Female vs. Male Contraception
If there are so many birth control methods for women, then why not the same for men? The exponential
difference, which separates the population into two, seemingly unequal markets, is a fairly basic physiological
difference: birth control pills trick the ovaries with hormones to make them believe a woman is pregnant so
ovulation will stop, whilst there is no similar situation for male sperm production, as it never stops, the way
ovulation does (Rinkunas, 2016).5 Unfortunately, such a key difference interrupts the mirroring of a similar
contraceptive for men, and leaves researchers and scientists to find alternative options to aid prevent pregnancies.
Moreover, another clear difference between the classes would be that as women usually release one egg
every month, men produce 1,000 sperm per second, and even if new sperm production is obstructed, men could
still impregnate women for three months. Additionally, as men are fertile for much longer than women,6 and
contraception proves to be a continuous issue for them, reversible birth control for sperm-wielders would take
3 Rinkunas, S., 2016. The Reason We Don't Have Male Birth Control Is Simpler Than You Think. [online] The Cut.
Available at: <https://www.thecut.com/2016/07/real-reason-we-dont-have-male-birth-control.html> [Accessed 2 December
2021].
4 Medlineplus.gov. 2021. Birth Control | Contraception | Contraceptives | MedlinePlus. [online] Available at:
<https://medlineplus.gov/birthcontrol.html> [Accessed 2 December 2021].
5 Rinkunas, S., 2016. The Reason We Don't Have Male Birth Control Is Simpler Than You Think. [online] The Cut.
Available at: <https://www.thecut.com/2016/07/real-reason-we-dont-have-male-birth-control.html> [Accessed 2 December
2021].
6 https://www.nichd.nih.gov/. 2021. How common is infertility?. [online] Available at:
<https://www.nichd.nih.gov/health/topics/infertility/conditioninfo/common> [Accessed 2 December 2021].
3. 3
longer to manufacture for the physiological differences between these alone, notwithstanding the side effects and
funding issues that present simultaneously (How common is infertility?, 2021).
DRUG TRIALS
Considering the anatomy of the male reproductive system, researchers seek different pathways to
implement and manufacture a male birth control pill. As the differences between the female and male reproductive
organs are prominent and key into this discussion, alternatives to the pill are also being manufactured, with the
same intent: serving as male birth control. Below, the essay will explore the first male contraceptive: Gossypol;
RISUG, a more current alternative; 11-beta-MNTC, a hormone contraceptive initiative; and Vasalgel, a sperm
blocking gel.
Side Effects
An important aspect of male contraception methods are the side effects that these may present. Like the
female birth control pill, a key aspect of it is that the effects are efficient, but most importantly reversible. Whether
the male pill would lower testosterone levels, sperm swimming capabilities, or sperm production numbers, it is
essential that the pill produced can obtain easy reversal and allow regular sperm production in the future, seeking
to prevent unintended pregnancies, yet not sterilize men and lower birth rates. Furthermore, another side effect
considered is lowered sex drive and erectile dysfunction. Some male contraceptives that are no longer utilized,
seeked to lower testosterone levels and thus, sperm production, however, blocking these hormones to the extent
necessary could result in these unintended consequences.
Gossypol
4. 4
One of the first avenues to non-hormonal male contraception was Gossypol. During the late 1970s,
Chinese researchers began extensive studies and clinical trials on the consumption of gossypol, a derivative of
cotton plant, as a male contraceptive, which reduced fertility. Two large phase III studies involving more than
8000 men concluded that gossypol reduced both sperm production and sperm motility (Meriggiola and Gemzell-
Danielsson, n.d.),7 and reported high efficacy, reversibility, and few side effects (Gossypol, 2018).8 The promising
compound, with 90% efficacy, unfortunately was largely abandoned as it caused troubling hypokalemia, and
around 20% of men did not have a return of fertility (Meriggiola and Gemzell-Danielsson, n.d.).9
RISUG
The Reversible Inhibition of Sperm Under Guidance (RISUG), is an injectable compound gel currently
under phase III clinical trial in India. It is a no-scalpel technique which provides contraception for at least 8 to 10
years (Thakur, Choudhary, Mehta and Kumar, 2013).10 RISUG is administered into the vas deferens, which is the
duct that conveys the sperm from the testicle to the urethra, and as it comes into contact with the spermatozoa
(sperm) it causes and imbalance on the sperm membrane, causing it to swell and rupture the acrosome (head) and
leak enzymes necessary for fertilization (Thakur, Choudhary, Mehta and Kumar, 2013).11 The membrane
disruption and release of enzymes can be seen in Figure 1. Although studies are continuously being conducted,
these are not yet approved for human trials and thus, even the effectiveness of RISUG and its simple reversal
qualities are yet to be further investigated.
7 Meriggiola, M. and Gemzell-Danielsson, K., n.d. Female and Male Contraception.
8 ScienceDirect. 2018. Gossypol. [online] Available at: <https://www.sciencedirect.com/topics/agricultural-and-
biological-sciences/gossypol>[Accessed 2December 2021].
9 Meriggiola, M. and Gemzell-Danielsson, K., n.d. Female and Male Contraception.
10 Thakur, V., Choudhary, M., Mehta, V. and Kumar, D., 2013. RISUG: A new perspective in non–hormonal male
contraception. [online] ScienceDirect. Available at:
<https://www.sciencedirect.com/science/article/pii/S2305050013601384> [Accessed 2 December 2021].
11 Thakur, V., Choudhary, M., Mehta, V. and Kumar, D., 2013. RISUG: A new perspective in non–hormonal male
contraception. [online] ScienceDirect. Available at:
<https://www.sciencedirect.com/science/article/pii/S2305050013601384> [Accessed 2 December 2021].
5. 5
Figure 1.
Membrane disruption due to RISUG interaction
Source: Thakur, V., et al., 2013. RISUG: A new perspective in non–hormonal male contraception. [online]
11-beta-MNTDC
The new phase I trial male pill, led by researchers at the University of Washington School of Medicine
along with UCLA, in the US, has seen positive results. There were 40 men included in the study, though at least
60 to 90 days are required to affect sperm production levels, and the side effects: mild fatigue, acne and headache,
would be reversible after stopping treatment (Phase I trial of 11-beta-MNTDC reveals positive results, 2021).12 It
works by mimicking testosterone, and for the 30 who took the experimental drug, showed that the levels of
hormones needed for sperm production dropped significantly compared to those taking the placebo, and then
returned to normal levels after the trials (Male pill - why are we still waiting?, 2021).13
12 Clinicaltrialsarena.com. 2021. Phase I trial of 11-beta-MNTDC reveals positive results. [online] Available at:
<https://www.clinicaltrialsarena.com/news/trial-11-beta-mntdc/> [Accessed 2 December 2021].
13 BBC News. 2021. Male pill - why are we still waiting?. [online] Available at:
<https://www.bbc.com/news/health-47691567> [Accessed 2 December 2021].
6. 6
Vasalgel
The new male contraceptive under development is called Vasalgel, a polymer (molecular structure of
similar units bonded together) that when administered into the vas deferens, it sets as a gel, blocking the flow of
sperm (Vasalgel - Revolution Contraceptives, 2021).14 Like a female IUD, it is expected to have a long-acting
effect, and be removed once future fertility is desired. Recent rabbit studies suggest and depict a rapid restoration
of sperm flow after flushing the vas deferens (Vasalgel - Revolution Contraceptives, 2021).15 Nonetheless, more
clinical testing is still required to determine the years the effect of Vasalgel will last.
SHARED CONTRACEPTIVE RESPONSIBILITY
A major impediment to the male contraceptive pill is the responsibility. In a relationship, or a casual
situation, it is fairly dubious whether the woman would trust the man would actually take the pill. Subsequently,
the woman would continue to take plan B, and thus decrease the importance or demand of male birth control, not
being a good quality for the market and to gain funding. Actually, a poll done by the University of Teesside
showed that while men would welcome it, their partners did not believe they could be trusted to take the
contraceptive pill regularly, and even a portion of men said they would not trust themselves to take the pill
everyday, possibly leading to unintended pregnancies (Can men be trusted to take male contraceptive pill?,
2021).16
CONCLUSION
14 Revolution Contraceptives. 2021. Vasalgel - Revolution Contraceptives. [online] Available at:
<https://www.revolutioncontraceptives.com/vasalgel/#1519942596148-cf1108da-58bd> [Accessed 2 December 2021].
15 Revolution Contraceptives. 2021. Vasalgel - Revolution Contraceptives. [online] Available at:
<https://www.revolutioncontraceptives.com/vasalgel/#1519942596148-cf1108da-58bd> [Accessed 2 December 2021].
16 Science Daily. 2021. Can men be trusted to take male contraceptive pill?. [online] Available at:
<https://www.sciencedaily.com/releases/2010/01/100128110227.htm> [Accessed 2 December 2021].
7. 7
Today, the aforementioned contraceptives (and others) are under extensive research and development.
However, the adversities that most of the pharmaceutical companies producing these products face, as discussed
above, could potentially halt the investigations, especially considering how this research began in the 1970s, and
an effective pill for men is yet to be concluded, or presented. The lack of funding for research is an important
consideration for the issue, yet the most substantial impediment are the side effects that the current hormonal and
non-hormonal methods are trying to reduce and prevent to achieve a, truly, reversible birth control.
8. 8
REFERENCES
Bakare, T., 2019. ‘The pill’ for guys: Male birth control option passes safety tests: UT Southwestern -
MedBlog. [online] Utswmed.org. Available at: <https://utswmed.org/medblog/pill-guys-male-
birth-control-option-passes-safety-tests/> [Accessed 2 December 2021].
BBC News. 2021. Male pill - why are we still waiting?. [online] Available at:
<https://www.bbc.com/news/health-47691567> [Accessed 2 December 2021].
Clinicaltrialsarena.com. 2021. Phase I trial of 11-beta-MNTDC reveals positive results. [online]
Available at: <https://www.clinicaltrialsarena.com/news/trial-11-beta-mntdc/> [Accessed 2
December 2021].
Majumdar, M., 2018. Safe, Effective Male Contraceptive Pill - The Long Wait. [online] Medindia.
Available at: <https://www.medindia.net/patients/patientinfo/safe-effective-male-contraceptive-
pill-the-long-wait.htm> [Accessed 2 December 2021].
Medlineplus.gov. 2021. Birth Control | Contraception | Contraceptives | MedlinePlus. [online]
Available at: <https://medlineplus.gov/birthcontrol.html> [Accessed 2 December 2021].
Meriggiola, M. and Gemzell-Danielsson, K., n.d. Female and Male Contraception.
Revolution Contraceptives. 2021. Vasalgel - Revolution Contraceptives. [online] Available at:
<https://www.revolutioncontraceptives.com/vasalgel/#1519942596148-cf1108da-58bd>
[Accessed 2 December 2021].
Rinkunas, S., 2016. The Reason We Don't Have Male Birth Control Is Simpler Than You Think. [online]
The Cut. Available at: <https://www.thecut.com/2016/07/real-reason-we-dont-have-male-birth-
control.html> [Accessed 2 December 2021].
9. 9
ScienceDirect. 2018. Gossypol. [online] Available at:
<https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/gossypol>
[Accessed 2 December 2021].
Science Daily. 2021. Can men be trusted to take male contraceptive pill?. [online] Available at:
<https://www.sciencedaily.com/releases/2010/01/100128110227.htm> [Accessed 2 December
2021].
Thakur, V., Choudhary, M., Mehta, V. and Kumar, D., 2013. RISUG: A new perspective in non–
hormonal male contraception. [online] ScienceDirect. Available at:
<https://www.sciencedirect.com/science/article/pii/S2305050013601384> [Accessed 2
December 2021].